Salmanian 2012.
Methods | Randomised controlled trial | |
Participants |
Setting: Islamic Republic of Iran. Duration of study: not reported. Participants randomised: N = 60 Inclusion criteria: “pregnant women (gestational age >40w), primigravida and gravida 2” other inclusion criteria not reported (Page S811). Exclusion criteria: not reported. Parity: mixed. Both nulliparous and multiparous women included (primigravida and gravida 2), however no data provided (Page S811). Bishop Score: mean of Bishop score change recorded only. Baseline and final Bishop scores not recorded (Page S811). |
|
Interventions |
Group A (N = not reported): membrane stripping Group B (N = not reported): PGE2 |
|
Outcomes | Data supports subgroup analysis only | |
Notes |
Funding: none declared Trial authors’ declaration of interest: none declared Informed consent obtained: not stated Ethical approval: not stated Email sent 5 June 2017 requesting further data. Email sent 28 September 2017 requesting further details. No reply to date. |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not reported. |
Allocation concealment (selection bias) | Unclear risk | Not reported. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants: not blinded. Personnel: unclear. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Attrition not reported. |
Selective reporting (reporting bias) | Unclear risk | No protocol available. Conference abstract only. |
Other bias | Low risk | No protocol available, conference abstract only. However, no other bias noted. |